GEM BioSoft (gembiosoft.com) is a spin-off from the UPV focused in the design, development and implementation of information systems, software and databases for biomedical and bioinformatics domains. Specifically, GEM´s main expertise is the development of tools that support health diagnosis from genetic data. The mission of the company is to promote the use of sound Information Systems concepts in the Bioinformatics domain, to provide high-quality solutions to the challenges of advanced Genomic Data Management and e-Health. GEM Biosoft multidisciplinary team is composed by biologists, software engineers and programmers.
The tools developed by GEM Biosoft are designed to help genetic diagnosis companies to optimize diagnosis process and maximize their time and human resources (DIAGEN / VarSearch), and to make genomic diagnosis available to the final user (www.geneslove.me). Automating this process (which should combine the same two key factors, such as speed and reliability of data)...
GEM BioSoft (gembiosoft.com) is a spin-off from the UPV focused in the design, development and implementation of information systems, software and databases for biomedical and bioinformatics domains. Specifically, GEM´s main expertise is the development of tools that support health diagnosis from genetic data. The mission of the company is to promote the use of sound Information Systems concepts in the Bioinformatics domain, to provide high-quality solutions to the challenges of advanced Genomic Data Management and e-Health. GEM Biosoft multidisciplinary team is composed by biologists, software engineers and programmers.
The tools developed by GEM Biosoft are designed to help genetic diagnosis companies to optimize diagnosis process and maximize their time and human resources (DIAGEN / VarSearch), and to make genomic diagnosis available to the final user (www.geneslove.me). Automating this process (which should combine the same two key factors, such as speed and reliability of data) will have a direct impact in achieving significant improvements in medicine and genomics.
More information

Investors

FINODEX
Admin
FINODEX Future Internet Open Data Expansion

Advisors

Francisco Valverde
Admin
Francisco Valverde